SCHEMBL5952618

SCHEMBL5952618

CC(C)OB(Cc1ccccc1)OC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
SIGMAR1 Q99720 5/20 0.40
TAAR1 Q96RJ0 4/20 0.40
SLC6A2 P23975 2/20 0.40
MAOA P21397 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
CYP2A6 P11509 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
HTT P42858 1/20 0.40
SLC18A2 Q05940 1/20 0.38
CYP2D6 P10635 1/20 0.38
TP53 P04637 1/20 0.37
TRPA1 O75762 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LTA4H P09960 1/20 0.35
CNR2 P34972 1/20 0.35
CALM1 P0DP23 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3901460 0.75 TP53 (0.42) TSHRTP53TRPA1LTA4HCALM1
SCHEMBL7215809 0.68 TSHR (0.40) TSHRSIGMAR1TAAR1SLC6A2MAOA
Methyl Alcohol SCHEMBL28147273 0.68 TSHR (0.44) TSHRHTT
SCHEMBL92354 0.67 CA1 (0.44) TSHRSIGMAR1TAAR1SLC6A2MAOA
SCHEMBL5952437 0.67 CYP2D6 (0.43) TSHRSIGMAR1TAAR1SLC6A2MAOA
SCHEMBL12400987 0.66 TP53 (0.48) TSHRSIGMAR1TAAR1SLC6A2MAOA
SCHEMBL15003 0.65 TSHR (0.52) TSHRSIGMAR1TAAR1SLC6A2MAOA
SCHEMBL2400555 0.65 ORAI1 (0.40) TSHRCYP2D6TP53MEN1KMT2A
SCHEMBL7461066 0.65 ORAI1 (0.52) TSHRTAAR1SLC6A2MAOASLC6A4
SCHEMBL17508991 0.65 EPHX2 (0.38) TSHRTP53TRPA1CALM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A TSHR 4624/4885SIGMAR1 3038/4885TAAR1 3746/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 TSHR 4667/4885SIGMAR1 2661/4885TAAR1 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.